CareDx (CDNA) Misses Q3 EPS by 4c

CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $7.34 million.

CareDx confirmed its revenue guidance for the full year 2015 of $28 to $30 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy
• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral